发明名称 ARYL ANILINE 2 ADRENERGIC RECEPTOR AGONISTS
摘要 The invention provides novel beta 2 adrenergic receptor agonist compounds of formula (I): wherein R 1-R13 and w have any of the values described in the specification. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with beta2 adrenergic receptor activity, and processes and intermediates useful for preparing such compounds.
申请公布号 KR20050044400(A) 申请公布日期 2005.05.12
申请号 KR20047007123 申请日期 2002.11.12
申请人 THERAVANCE, INC. 发明人 MORAN, EDMUND J.;NODWELL, MATTHEW B.;AGGEN, JAMES;CHURCH, TIMOTHY J.;JACOBSEN, JOHN R.;LEADBETTER, MICHAEL R.;TRAPP, SEAN G.
分类号 C07D295/22;A61K31/136;A61K31/16;A61K31/18;A61K31/245;A61K31/357;A61K31/366;A61K31/4152;A61K31/426;A61K31/4402;A61K31/4453;A61K31/4704;A61K31/4709;A61K31/505;A61K31/5375;A61K31/5377;A61K31/63;A61K31/635;A61K45/00;A61P9/00;A61P11/00;A61P11/06;A61P15/06;A61P25/00;A61P29/00;A61P43/00;C07C215/60;C07C217/84;C07C217/86;C07C229/38;C07C229/60;C07C233/43;C07C311/44;C07C317/36;C07C323/36;C07C323/37;C07D213/75;C07D213/76;C07D215/22;C07D215/227;C07D215/26;C07D231/22;C07D239/38;C07D239/42;C07D239/46;C07D239/47;C07D277/20;C07D277/46;C07D277/52;C07D311/80;C07D319/18;C07D321/10;C07D401/12;C07D405/12;C07D409/12;C07D413/12;(IPC1-7):C07C215/14 主分类号 C07D295/22
代理机构 代理人
主权项
地址